Target validation: Validation of the RNA helicase eIF4A as a broad-spectrum antiviral target (HELIATAR) - Possible development of resistance and elucidation of the resistance mechanisms involved
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16GW0261
Grant search
Key facts
Disease
N/AStart & end year
20202022Known Financial Commitments (USD)
$248,531.44Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
Justus-Liebig-Universität GießenResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable